Plasminogen Activator Inhibitor-1 Promotes Neutrophil Infiltration and Tissue Injury on Ischemia–ReperfusionHighlights
Jump to

Visual Overview
Abstract
Objective—Ischemia–reperfusion (I/R) injury significantly contributes to organ dysfunction and failure after myocardial infarction, stroke, and transplantation. In addition to its established role in the fibrinolytic system, plasminogen activator inhibitor-1 has recently been implicated in the pathogenesis of I/R injury. The underlying mechanisms remain largely obscure.
Approach and Results—Using different in vivo microscopy techniques as well as ex vivo analyses and in vitro assays, we identified that plasminogen activator inhibitor-1 rapidly accumulates on microvascular endothelial cells on I/R enabling this protease inhibitor to exhibit previously unrecognized functional properties by inducing an increase in the affinity of β2 integrins in intravascularly rolling neutrophils. These events are mediated through low-density lipoprotein receptor–related protein-1 and mitogen-activated protein kinase–dependent signaling pathways that initiate intravascular adherence of these immune cells to the microvascular endothelium. Subsequent to this process, extravasating neutrophils disrupt endothelial junctions and promote the postischemic microvascular leakage. Conversely, deficiency of plasminogen activator inhibitor-1 effectively reversed leukocyte infiltration, microvascular dysfunction, and tissue injury on experimental I/R without exhibiting side effects on microvascular hemostasis.
Conclusions—Our experimental data provide novel insights into the nonfibrinolytic properties of the fibrinolytic system and emphasize plasminogen activator inhibitor-1 as a promising target for the prevention and treatment of I/R injury.
- fibrinolysis
- leukocyte
- mitogen-activated protein kinases
- plasminogen activator inhibitor 1
- reperfusion injury
- Received June 2, 2017.
- Accepted January 15, 2018.
- © 2018 American Heart Association, Inc.
Highlights
American Heart Association Professional?
Log in using your username and password
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
This Issue
Jump to
Article Tools
- Plasminogen Activator Inhibitor-1 Promotes Neutrophil Infiltration and Tissue Injury on Ischemia–ReperfusionHighlightsMarc Praetner, Gabriele Zuchtriegel, Martin Holzer, Bernd Uhl, Johanna Schaubächer, Laura Mittmann, Matthias Fabritius, Robert Fürst, Stefan Zahler, Dominik Funken, Maximilian Lerchenberger, Andrej Khandoga, Sandip Kanse, Kirsten Lauber, Fritz Krombach and Christoph A. ReichelArteriosclerosis, Thrombosis, and Vascular Biology. 2018;38:829-842, originally published January 25, 2018https://doi.org/10.1161/ATVBAHA.117.309760
Citation Manager Formats
Share this Article
- Plasminogen Activator Inhibitor-1 Promotes Neutrophil Infiltration and Tissue Injury on Ischemia–ReperfusionHighlightsMarc Praetner, Gabriele Zuchtriegel, Martin Holzer, Bernd Uhl, Johanna Schaubächer, Laura Mittmann, Matthias Fabritius, Robert Fürst, Stefan Zahler, Dominik Funken, Maximilian Lerchenberger, Andrej Khandoga, Sandip Kanse, Kirsten Lauber, Fritz Krombach and Christoph A. ReichelArteriosclerosis, Thrombosis, and Vascular Biology. 2018;38:829-842, originally published January 25, 2018https://doi.org/10.1161/ATVBAHA.117.309760